Prevent fraud and avoid being scammed


Research finds that 87% of consumers choose generic drugs

According to recent research, nearly nine outstated that more than 70 brand name drugs,
of 10 clients decide to substitute commonincluding 19 blockbusters, are losing their
brand name drugs by their generic versionspatent protection within the next five years
within a few weeks of when these cheapest- with total yearly sales of $45 billion. If
drugs become obtainable. The researchersMedco's study reveals a long-term trend, in
analyzed four drugs: Allegra, Arava, Amarylthe coming years consumers, employers and
and Zithromax. In the second half of 2005,insurance companies will save billions of
each of these drugs run out of patentdollars in prescription drug - Smith said.
protection. Their generic equivalents wereThe data met with enthusiastic reaction from
bought instead at an average factor of 87consumer groups. "We hope the trend
percent within 30 days of the equivalent'scontinues. It's good for consumers,"
delivery at pharmacies. The research wasconfessed Bill Vaughan, senior policy analyst
organized by Medco Health Solutions Inc.for an advocacy group, Consumer Union, based
based in Frankin Lakes, which is the biggestin Washington, D.C. Vaughan mentioned that
drug benefit management company in U.S. Thepast fears concerning the effectiveness and
company bargains for low prices ofsafety of generic drugs have apparently
prescription drug on behalf of its customers.started to fade away as society has become
According to the study, Zithromax, themore concerned about rapid increase of
blockbuster of Pfizer Inc. with its annualhealth-care costs. "The FDA approves these
sales of $1.85 billion was rapidlygeneric drugs because they have been
substituted at pharmacies by genericdetermined just as safe and effective as
equivalent at a 90 percent rate just after ittheir brand name counterparts, but you pay a
lost its patent protection in November. Thefraction of the price," Vaughan stated. "We
study authors mentioned the substitution ofthink this is very positive and can save
Zithromax, an antibiotic for respiratoryconsumers literally billions of dollars in
infections, as evidence that more and morethe next few years." At the same time, large
doctors prescribe generic versions of brandpharmaceutical companies have claimed that
name drugs more easily, even if it is abouttheir brand name drugs will not be
so-called acute care drugs, such assubstituted by knockoffs as insurers and
Zithromax. "The really good news is thatdoctors realize that the brand name drugs
these four generic medications are just theguarantee better care and in consequence -
start. With a number of popular medicationssave money. Hank McKinnell, Pfizer Chairman
expected to move off patent in the nextused that argument during last session with
several years, we should see substantialanalysts in New York. "If you don't like the
prescription drug costs savings" - stated ahigh cost of health care, try the high cost
Medco senior vice president, Dr. Glenof sickness," McKinnell advised.
Stettin. A spokeswoman at Medco, Ann Smith



1 A B C D E 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118